Rimonabant Acomplia Helps With Weight Loss
Rimonabant acomplia diet weight loss pills are approved now and will be available on sale in all of 25 European Union Countries in July.
The European Commission gave permission for the sale of Rimonabant acomplia prescription weight loss drugs to treat obesity and weight loss with a BMI ( body mass index) of 30 or above as well as for smoking cessation treatments.
“The approval of Rimonabant Acomplia in the European Union is important news for obese and overweight patients with additional cardiometabolic risk factors such as type 2 diabetes or dyslipidaemia who will now have access to an innovative treatment option,” said Sanofi CEO Jean-François Dehecq.
Sanofi said that after the launch of Acomplia (Rimonabant) in the United Kingdom, it will be launched during the second half of 2006 in Denmark, Ireland, Germany, Finland and Norway as well.
Acomplia is different from most other weight loss pills available in the market today in the sense that it does not act on any of the known weight gain factors but uses a totally different approach for weight loss.
Many legitimate Web sites bring customers health products with the benefits of convenience, privacy, and, sometimes, cheaper prices. “But consumers need to be aware that the Internet has also created a marketplace for unapproved medical products, illegal prescribing, and products marketed with fraudulent health claims. So, Being a responsible website, cesaonline.com encourages visitors to go through all the information available about Rimonabant before order rimonabant acomplia online from UK.
Now it is easy to Order Rimonabant a slimming pill online. Now no more exercise, no more weight loss programs and no more machines to reduce your weight and control it. One wonder durg Rimonabant Acomplia can do all for you. Apart from being an effective weight loss and an anti obesity pill, Rimonabant Acomplia has also shown to improve HDL (good cholesterol) and triglyceride levels, showing benefit for diabetes and heart conditions.
Rimonabant Acomplia Discount » Blog Archive » Rimonabant acomplia says:
[…] Rimonabant acomplia is an anorectic anti obesity drug. It is a CB1 cannabinoid receptor antagonist. Its main avenue of effect is reduction in appetite. Obesity is now the most common nutritional disorder in western countries. Defined as a body mass index of greater than 30, it arises from the accumulation of excess fat in the body from overconsumption of fatty foods. […]
14 January 2008, 9:28 am